M
Minnesota Epilepsy Group, P.A. | Roseville, MN
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Clemizole Hydrochloride
EPX-100
BHV-7000
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Enrolling
Focal Epilepsy
Drug: BHV-7000
Drug: Placebo
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX...
Enrolling
Lennox Gastaut Syndrome
Drug: Clemizole HCl
Drug: Placebo
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Invitation-only
Focal Epilepsy
Drug: BHV-7000
Trial sponsors
E
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems